Methylation test for anal cancer screening
Part of Cancer, Digestive system, Women’s health & pregnancy clinical trials.
This study is testing a new way to screen for anal cancer by looking at DNA methylation in cells collected from the anus. It may help people at higher risk for anal cancer find out earlier if they need further tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be eligible for anal cancer screening based on guidelines, which includes: men who have sex with men over 30 with HIV, people who have had a solid organ transplant for more than 10 years, or women with a history of vulvar lesions or vulvar cancer.
- You cannot be currently under follow-up for a high-grade anal lesion or anal cancer.
- You cannot be pregnant or breastfeeding.
- You must be willing to collect your own anal sample at home.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether having people collect their own anal samples at home can help find and treat early signs of anal cancer. It is for men and transgender women who have sex with men and who live in or near Chicago, Houston, or Milwaukee.
This study is screening gay and bisexual men for anal cancer by taking a swab sample. It aims to find early signs of cancer so it can be treated early.
This study looks at using a simple swab to screen for HPV (the virus that can cause anal cancer) in people living with HIV. By collecting a sample from the anal area, the study aims to find a less invasive way to check for risk, helping you avoid more uncomfortable procedures unless needed.
This study tests how well a special HPV test (called BD Onclarity™) can find anal cancer or precancer. It is for people at high risk or with known anal abnormalities, and aims to improve early detection.
This study tests whether regular blood tests looking for “tumor DNA” can help guide your follow-up care after anal cancer treatment. It may help doctors decide what type of monitoring you need during check-ups.
This trial checks whether tumor samples contain HPV DNA (genetic material from the HPV virus). The goal is to improve detection in anal and cervical cancers, especially in patients planning standard radiation treatment.
Hear when a new Anal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.